PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction
Ranking
Overall
75
Content
90
Popularity
39
Observed public metrics from 1 member.
Merged summary
TL;DR - PerturbRx predicts patient-level cancer drug response by learning treatment- and dose-conditioned latent molecular transitions from single-cell perturbation data. It improves aggregate performance on TCGA and patient-derived xenograft benchmarks without requiring patients’ post-treatment measurements.
- Learns intervention-induced transitions from context-matched but unpaired control and treated single-cell populations.
- Freezes and transfers the pretrained transition predictor to pretreatment patient molecular profiles.
- Combines predicted transitions with patient and drug representations for response prediction.
- Addresses data scarcity and tumor heterogeneity by explicitly modeling expected treatment-driven molecular changes.
Sources (1)
PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction
Public signals
Semantic Scholar citations 0 · Semantic Scholar influential citations 0
TL;DR - PerturbRx predicts patient-level cancer drug response by learning treatment- and dose-conditioned latent molecular transitions from single-cell perturbation data. It improves aggregate performance on TCGA and patient-derived xenograft benchmarks without requiring patients’ post-treatment measurements.
- Learns intervention-induced transitions from context-matched but unpaired control and treated single-cell populations.
- Freezes and transfers the pretrained transition predictor to pretreatment patient molecular profiles.
- Combines predicted transitions with patient and drug representations for response prediction.
- Addresses data scarcity and tumor heterogeneity by explicitly modeling expected treatment-driven molecular changes.